Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 20, 2019
Pharmacy Choice - News - U.S. Pharmaceutical Industry - January 20, 2019

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

1/19/19 - AIVITA gets IND nod for Phase 1B melanoma trial [Syrian Arab News Agency]
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for a Phase 1 B clinical trial investigating the Company`s ROOT OF CANCER technology in patients with metastatic melanoma. AIVITA`s ROOT OF CANCER...
1/19/19 - Alphabet's health division gets clearance for on-demand ECG feature in smartwatch [Asian News International]
California, January 19: After Apple, Google' s parent company Alphabet is working its way towards bringing health at the center of its products. Now, the company's health division Verily has reportedly received FDA 510 clearance for its Study smartwatch for an on-demand ECG feature. The feature is increasingly becoming a standard for a lot of manuf
1/19/19 - Antibody Drug Conjugates Market Set to Garner Staggering Revenues by 2020
Albany, NY 01/19/2019 The global Antibody Drug Conjugates Market are very effective biopharmaceuticals developed as the targeted therapeutic helpful in the treatment of Cancer. Antibody drugs conjugates are further designed to eradicate the cancer cells without harming the normal cells. Of these, Adcertis drug segment dominate this market due
1/19/19 - Automated Microbiology Testing Market: North America is the most dominating region for this market
"Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on the gamut of sectors across the globe" The aging workforce in laboratory tests, the growing demand for high quality laboratory services and the growing need for fast results will lead to the expansion of the global market fo
1/19/19 - Bee Pollen Supplements Market Soaring Demand Assures Motivated Revenue Share During 2018 to 2026: Fact.MR has announced the addition of the Bee Pollen Supplements Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 201
Rockville, MD 01/19/2019 Bee pollen is a mixture of pollens picked by bees, bee saliva, and some nectar. Bee pollen Supplements have been popular for its high nutrient content and medicinal properties. German Federal Board of Health has recognized bee pollen supplements as medicine, owing to its medicinal benefits.
1/19/19 - Big Pharma Poised for Disruption in 2019 While Mid-Tier Companies Double Down on Innovation
Jones Lang LaSalle issued the following news release:. Small and mid-tier companies are responsible for 63 percent of new products brought to market since 2013, according to HBM Partners, making 2019 the year for Big Pharma to add more innovation to its business model. "Without productive, efficient R&D processes that deliver strong revenues to dr
1/19/19 - Biosimilar Drugs Market - a Cost-Saving Option to Expensive Biologics: Overview of How Much Have CMOs Benefited from Biosimilars
Albany, NY 01/19/2019 Biosimilars are drugs that are highly similar but not identical to branded innovator biologics: large molecule, immunogenic drugs produced from living cells. Innovator biologics are the first to be approved, and when their patent protection expires, biosimilars may be approved, in a similar way to small molecule branded
1/19/19 - Business Digest
Waltham-based AMAG Pharmaceuticals said it has completed a previously announced acquisition of Perosphere Pharmaceuticals, a private biopharmaceutical company. Through this acquisition, AMAG adds ciraparantag to its development portfolio. Ciraparantag has been granted fast track review designation by the U.S. Food and Drug Administration and has...
1/19/19 - Cancer Comorbidities Adversely Associated With Clinical Trial Participation [T-break Tech (Middle East)]
The American Society of Clinical Oncology, Friends of Cancer Research, and the US Food and Drug Administration recently recommended modernizing criteria related to comorbidities routinely used to exclude patients from cancer clinical trials. The goal was to design clinical trial eligibility such that trial results better reflect real-world cancer..
1/19/19 - Contact Lens Market: Increase in Demand and Approvals for Contact Lens to Propel the Market Growth
Albany, NY 01/19/2019 Transparency Market Research has published a new report titled, "Contact Lens Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 2026". According to the report, the global contact lens market was valued at US$ 11,155.7 Mn in 2017 and is anticipated to expand at a CAGR of 7.4% during fore
1/19/19 - Cystinosis Research Foundation Announces Federal Drug Administration Approval for First Human Clinical Trials [Tehran Times (Iran)]
The Cystinosis Research Foundation, the largest provider of grants for cystinosis research in the world, today announced that the Federal Drug Administration granted approval for the first human clinical trial for stem cell and gene therapy treatment for cystinosis. Over the last 12 years, CRF has provided more than $4.3 million in research funding
1/19/19 - Daewoong, SK Biopharm struggle on US gov't shutdown [Korea Times]
By Jun Ji- hye The ongoing US government shutdown has left Korean drug companies hanging, including Daewoong Pharmaceutical and SK Biopharmaceuticals, as the closed Food and Drug Administration has been unable to review and approve medicines. Daewoong Pharmaceutical has been waiting for FDA approval for its botulinum toxin product, called Nabota Th
1/19/19 - Drug Delivery Systems Marketto Reach Approximately US $900 Bn by 2025
Albany, NY 01/19/2019 Transparency Market Research has published a new report titled " Drug Delivery System Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 2025". Key players introduce new drugs delivery systems and devices in developed markets such a North America and Western Europe. Rise in R&D investmen
1/19/19 - Global Hemophilia Treatment Drugs Market: Biopharm Titans Invest in Novel Coagulation Factor Discoveries
Albany, NY 01/19/2019 The hemophilia treatment drugs market is likely to slate robust growth with surged investments towards healthcare infrastructure globally. Further, emergence of novel coagulating factors as well as rising prevalence of hemophilia are other potential growth catalysts in global hemophilia treatment drugs market.
1/19/19 - Head and Neck Cancer Market Is Driven by Increase in the Patient Population and Surge in Research and Development Activity
Albany, NY 01/19/2019 Transparency Market Research has published a new report titled, "Head and Neck Cancer Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 2026". According to the report, the global head and neck cancer market was valued at US$ 933.3 Mn in 2017 and is anticipated expand at a CAGR of 9.2% f
1/19/19 - HKUST and Pangu BioPharma (an ATyr Pharma Subsidiary) Recognized for Pioneering Work Leading to New Investigational Therapeutic for Lung Disease
The University of Science and Technology issued the following news release:. -Researchers from The Hong Kong University of Science and Technology credited with important translational science and early discovery work. SAN DIEGO AND HONG KONG- aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicin
1/19/19 - Jon Lender: Doctor pleads guilty in compound medicine case that defrauded Connecticut taxpayers [The Hartford Courant]
Jan. 19 A physician pleaded guilty Friday in U.S. District Court in New Haven to a count of conspiracy to commit health care fraud in an alleged scheme with her husband to defraud Connecticut's state-employee prescription benefit plan, as well as other government health programs, by submitting prescriptions for very expensive "compound medicati
1/19/19 - Kitov Closes $6 Million Registered Direct Offering [Sport360]
-Kitov Pharma Ltd., an innovative pharmaceutical company, today announced the closing of its previously announced registered direct offering of 3,428,572 American Depositary Shares at a purchase price of $1.75 per ADS, for gross proceeds of $6 million. Copies of the final prospectus supplement and the accompanying prospectus relating to the registe
1/19/19 - Kura Oncology Reports Clinical Activity of Tipifarnib in Subsets of Pancreatic Cancer Associated with High CXCL12 Expression [Tehran Times (Iran)]
-Kura Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, reported new findings identifying a potential association between CXCL12 expression and clinical benefit in patients with pancreatic cancer treated with tipifarnib. These findings are being presented today at the 2019...
1/19/19 - Lawsuits ramp up pressure on family that owns opioid company Lawsuits ramp up pressure on family that owns opioid company
The Sackler family came under heavy scrutiny this week when a legal filing in a Massachusetts case asserted that family members and company executives sought to push prescriptions of the drug and downplay its risks. Members of the family that controls Connecticut- based Purdue Pharma are also defendants in a lawsuit brought by New York's Suffolk Co
1/19/19 - Legislation would target prescription drug costs
Tammy Baldwin, D- Wis., joined U.S. Sen. In the House of Representatives, the bipartisan companion bill is led by U.S. Reps. Peter Welch, D- Vt., and Francis Rooney, R- Fla..
1/19/19 - Luye Pharma strengthens commitment to cardiovascular therapeutic field [Sudan Tribune]
Luye Pharma has entered an agreement with AstraZeneca China, the terms of which grant AstraZeneca China exclusive rights to promote Luye Pharma`s Xuezhikang Capsules in mainland China. This is the first time that a multinational pharmaceutical company has gained exclusive authorization in China to promote an innovative drug independently developed
1/19/19 - Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases [Sudan Tribune]
-The Icahn School of Medicine at Mount Sinai has entered into two exclusive licenses to develop the drug pentosan polysulfate sodium for the treatment of mucopolysaccharidosis, with Australia- based company Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. of Japan. Calogera Simonaro, PhD, Research Professor in the Department of Genetics an
1/19/19 - Mount Sinai Partners With Paradigm Biopharmaceuticals Ltd., ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases
The Ichan School of Medicine at Mount Sinai issued the following news release:. The Icahn School of Medicine at Mount Sinai has entered into two exclusive licenses to develop the drug pentosan polysulfate sodium for the treatment of mucopolysaccharidosis, with Australia- based company Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. of Jap
1/19/19 - New Study Shows Physician-Targeted Marketing Is Associated With Increase in Opioid Overdose Deaths
Although prescription opioids are involved in more than one-third of all opioid overdose deaths in the United States, examining any correlation between prescription opioid overdose deaths and pharmaceutical industry marketing has been limiteduntil now. New research from NYU School of Medicine and Boston Medical Center published online January 18.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415